Apolipoproteins as predictors of ischaemic stroke in patients with a previous transient ischaemic attack
M Bhatia1, S C Howard, T G Clark
1Stroke Prevention Research Unit, Radcliffe Infirmary, Centre for Statistics in Medicine, University of Oxford, UK.
Insights
Apolipoprotein B and its ratio to apolipoprotein A1 are strong predictors of ischaemic stroke risk in patients with a history of transient ischaemic attack (TIA). These findings suggest improved stroke risk assessment using lipid sub-fractions.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Lipidology
Background:
- Traditional lipid markers (total cholesterol, LDL) show weak associations with ischaemic stroke compared to coronary heart disease.
- Statins effectively prevent both stroke and CHD, suggesting other lipid sub-fractions influence stroke risk.
- Apolipoprotein B is a stronger predictor of CHD than LDL cholesterol, but its role in stroke risk, especially post-TIA, is understudied.
Purpose of the Study:
- To investigate the association between baseline lipid sub-fractions, including apolipoproteins, and ischaemic stroke risk in patients with a history of transient ischaemic attack (TIA).
- To identify superior lipid biomarkers for predicting ischaemic stroke in this patient cohort.
Main Methods:
- Prospective cohort study of 261 patients with previous TIA.
- Assessment of baseline total cholesterol, LDL, HDL, apolipoprotein A1 (apo A1), and apolipoprotein B (apo B).
- Cox proportional hazards models used to analyze associations with ischaemic stroke risk over 10-year follow-up.
Main Results:
- The apolipoprotein B/apolipoprotein A1 ratio was the strongest independent predictor of ischaemic stroke (HR=2.94).
- Apolipoprotein B alone was also a significant independent predictor (HR=2.26).
- Total cholesterol, LDL, HDL, LDL/HDL ratio, and apo A1 did not show statistically significant associations with ischaemic stroke risk.
Conclusions:
- Apolipoprotein B and the apo B/apo A1 ratio are significant predictors of ischaemic stroke in patients with prior TIA.
- These apolipoprotein markers may offer improved prognostic value for ischaemic stroke risk assessment.
- Further research is needed to confirm these findings in patients on statin therapy.
Background:
Weak associations between total and LDL cholesterol and ischaemic stroke compared with coronary heart disease (CHD) are at odds with the similar effectiveness of statin drugs in preventing ischaemic stroke and CHD, suggesting that other lipid sub-fractions that are affected by statins might be better predictors of ischaemic stroke. Apolipoprotein B levels are reduced by statins and are a stronger predictor of CHD than total and LDL cholesterol in patients both on and off statins. However, there are very few published data on apolipoproteins and stroke risk and no studies in patients with previous transient ischaemic attack (TIA).
Methods:
We performed a prospective cohort study of the associations of baseline total cholesterol, LDL, HDL, apolipoproteins A1 and B (apo A1; apo B) and risk of ischaemic stroke in 261 patients with previous TIA. Cox proportional hazards models were used to determine crude and multivariate-adjusted hazard ratios (HR) above versus below median values at 10-years follow-up.
Results:
The apo B/apo A1 ratio was the strongest independent predictor of ischaemic stroke (HR=2.94, 95% CI 1.43-5.88, p=0.003) followed by apo B (HR=2.26, 95% CI 1.16-4.38, p=0.02). The associations between total cholesterol, LDL, HDL, LDL/HDL ratio and apo A1 and ischaemic stroke risk did not reach statistical significance.
Conclusions:
Apo B and the apo B/apo A1 ratio are predictive of ischaemic stroke in patients with previous TIA. Further studies are required to determine whether the prognostic value of apolipoprotein levels is maintained in patients on statins.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction


